Cyan Reef is an independent publisher and comparison service, not an investment advisor. Its articles, interactive tools and other content are provided to you for free, as self-help tools and for informational purposes only. They are not intended to provide investment advice. Cyan Reef is not compensated by the any third-party for the information published.

Pictet Health Fund

Instrument Profile

Short Description

All around the world, people are demanding a higher standard of living, including better healthcare, for themselves and their families. Pharmaceutical, medical, insurance and healthcare companies are finding new ways to meet this global challenge. Our Health strategy aims to identify the most attractive investment ideas in three areas: Innovation in the production of new medicines and biotech-generics; Further modernisation of equipment and services; and the Development of more effective tools and technology.
“We believe Health is more than the Healthcare sector, which mainly focuses on fixing disease when it’s already there. But not getting sick at all is much more effective. We believe consumers will play an increasingly important role in taking health into their own hands”, – Health Investment Team.

Type: Equity SICAV Geography: Broad Developed Markets
Sector: Diversified
Benchmark: MSCI AC World Hedged to EUR

Ongoing Charges: 1.17% (Estimated)
Initial Charge: 5.00%
Investment Style: Large-Cap Growth
Fund Size (AUM): EUR 594M

Data by the open sources of the instrument provider. Last update: 3.12.2020

MSCI Sustainability Score


Source: MSCI Inc.
Last update: Dec 3rd, 2020

Morningstar Sustainability Score


Source: Morningstar, Inc.
Last update: Dec 3rd, 2020

Rolling performance at 4/12/2020

1 Year: 8.96%

3 Years: 8.12%

5 Years: 4.57%

Performance data by the open sources of the instrument provider. Last update: 4.12.2020

Top 10 Holdings


Roche Holding AG

Abbott Laboratories

Thermo Fisher Scientific Inc

UnitedHealth Group Inc

Unilever NV

Merck & Co Inc

Boston Scientific Corp

Quest Diagnostics Inc

Waste Management Inc

Eli Lilly and Co












Top portfolio holdings as of 6.12.2020 | Source: instrument provider.

Interested in this instrument?

Join the community

Subscribe to receive the latest analytics and materials on impact investing.

The information made available to you does not constitute the giving of investment advice or an offer to sell or the solicitation of an offer to buy any security of any enterprise in any jurisdiction. The securities listed above are not registered and will not be registered for sale in the United Sates and cannot be purchased by U.S. investors as the securities can only be purchased in jurisdictions where they have been registered for sale or where an exemption from registration applies. The offer, sale or delivery of the securities within the United States or to, or for the account or benefit of, U.S. Persons is not permitted except pursuant to an exemption from registration under U.S. securities laws, which may not be available; and the availability of the information through the website does not alter or change the persons eligible to purchase the security. All information on this page is subject to Cyan Reef Terms & Conditions. The branding materials of the financial instruments displayed on this web-page are property of the respective instrument providers. Although the information provided was collected with due care, Cyan Reef does not and may not under any circumstances be responsible for the accuracy of the information provided hereby. All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Cyan Reef and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.